每周股票复盘：泽璟制药（688266）上半年营收3.76亿元同比增56.07%

Group 1 - The stock price of Zai Jian Pharmaceutical (688266) closed at 120.84 yuan on September 5, 2025, an increase of 18.46% from the previous week's 102.01 yuan [1] - The company's market capitalization is currently 31.987 billion yuan, ranking 18th out of 150 in the chemical pharmaceutical sector and 553rd out of 5152 in the A-share market [1] Group 2 - Zai Jian Pharmaceutical reported a revenue of 376 million yuan for the first half of 2025, representing a year-on-year growth of 56.07%, primarily driven by increased drug sales [2][3] - The company recorded a net loss of 72.8035 million yuan in the same period, with losses slightly widening compared to the previous year [2][3] - Research and development expenses amounted to 197 million yuan, accounting for 52.31% of total revenue [2][3]